Recent advances have significantly improved the drug screening process:
CRISPR-Cas9: This gene-editing technology allows for precise manipulation of genes, aiding in the identification of new drug targets. Artificial Intelligence (AI): AI and machine learning algorithms can analyze vast amounts of screening data to predict which compounds are most likely to succeed. Organoids: Miniature, 3D tissue cultures derived from patients' tumors provide a more accurate model for testing drug efficacy. Combination Therapies: Screening for drug combinations rather than single agents can identify synergistic effects that improve treatment outcomes.
